Virtual Conference

Ezzuddin A. Okmi

Saudi Public Health Authority , Saudi Arabia

Title: The effect of wet-cupping therapy (hijama) in modulating autoimmune activity of Hashimoto's thyroiditis: A pilot controlled study


Objectives: To investigate the possible effects of wet-cupping therapy (hijama) on autoimmune activity and thyroid hormonal profiles of Hashimoto's disease (HD) patients.
Methods: A prospective pilot controlled trial was carried out among adult females following HD at the Endocrinology Clinic of King Abdulaziz University Hospital, Jeddah, Saudi Arabia, from February 2014 until March 2017. A total of 13 patients (intervention group) underwent 3 hijama sessions at 3-week interval with a 6-month follow-up. Blood tests were carried out for both pre- and post-hijama, including: thyroid peroxidase antibody (TPO), thyroglobulin antibody (TG), thyroid stimulating hormone (TSH), thyroxine-4 (T4), and prolactin. Control group included 13 randomly selected HD patients following usual care with 2 consecutive measurements of TPO and TG at 2-3 months interval.
Results: Changes in anti-TPO and anti-TG showed a decrease in hijama group versus an increase in control group, and intervention group comparison was statistically significant. On a fixed thyroxine supplement for each patient, significant decrease in levels of anti-TPO, anti-TG, TSH, prolactin, and erythrocyte sedi-mentation rate (ESR) occurred.
Conclusion: These findings are presumptive to the efficacy of hijama on the pathogenesis of HD in modulating the immune inflammatory process demonstrated by the reduction in ESR, TPO, and TSH levels on a fixed thyroxin supplementation dose, along with patient-reported clinical improvement and positive changes in ultrasound including regaining of gland physiological size, echogenicity, and vascularity.


SBCM, (Saudi Board of Preventive and Community Medicine), Board Certified in Preventive Medicine, Jeddah, Saudi Arabia
M.B.B.S.,(The Bachelor Degree in Medicine and Surgery), July 2010,  Jazan University, Jazan City, Saudi Arabia (2003-2010) , GPA: 4.10 (very good)
2019- to Present    
Health Executive Expert and Preventive Medicine and Public Health Consultant,
Director  of  Communicable Respiratory diseases and TB  Prevention  and control  Directorate ,Saudi Public Health Authority, Riyadh, KSA
Preventive Medicine and Public Health Consultant in smoking cessation clinics primary health care centers of MOH , Riyadh ,KSA
2015- 2019      
Community and Preventive Medicine Resident, the Joint Program for Saudi Board of Community and Preventive Medicine, Jeddah, KSA: training in several hospitals as well as primary health care centers in the field of epidemiology, Biostatistics, Health informatics, preventive medicine, Research and infectious diseases control.